Adolescent Body Dysmorphic Disorder
Downloads
Published
How to Cite
Issue
Section
DOI:
https://doi.org/10.31766/revpsij.v37n4a3Keywords:
Body Dysmorphic Disorder, teenager, DSM-5, ICD-11, OCDAbstract
Body dysmorphic disorder (BDD) is characterized by preoccupation with nonexistent or slight defects in physical appearance, that cause clinically significant distress or impairment in social, occupational, or other important areas of functioning. Point prevalence of BDD is 1,7-2,5% in general population, with two thirds of the cases beginning in adolescence. There are significant classificatory differences to take into account. Whereas ICD-10 classifies it among Somatoform Disorders, DSM-5 and future ICD-11 do it among obsessive compulsive Disorder (OCD) and related Disorders. Furthermore, diagnostic doubts may arise with psychotic disorders or eating disorders. We present the case of a 16-years old girl, whose symptoms raised the questions previously exposed. We finally opted for BDD diagnosis, according to DSM-5 and ICD-11 classifications (OCD and related disorders). The patient was treated accordingly and she has progressed favorably. There are two main objectives in this article. First, to update the reader on the classificatory change of BDD in the ICD-11, which resembles the American point of view of this disorder, that is the one which we base our study on. Second, to deepen on the differential diagnosis, as it is not an easy task and this is evidenced by the classificatory change previously mentioned.
Downloads
References
American Psychiatric Association. Manual diagnóstico y estadístico de los trastornos mentales: DSM-5. Editorial médica Panamericana. 2014.
Salavert J, Clarabuch A, Trillo M. Trastorno Dismórfico Corporal: revisión sistemática de un trastorno propio de la adolescencia. Revista de psiquiatría infanto-juvenil 2019;36(1):4-19. https://doi.org/10.31766/revpsij.v36n1a1
Organización Mundial de la Salud. Guía de Bolsillo de la Clasificación CIE-10, Clasicación de los Trastornos Mentales y del Comportamiento. Madrid: Editorial Médica Panamericana. 2008.
Organización Mundial de la Salud. Clasificación de los Trastornos Mentales y del Comportamiento, 11ª revisión. Versión online. 2018.
Phillips KA. Pharmacotherapy for Body Dysmorphic Disorder. Psychiatr Ann 2010; 40(7):325-32. https://doi.org/10.3928/00485713-20100701-05
Harrison A, Fernández de la Cruz L, Enander J, Radua J, Mataix-cols D. Cognitive-behavioral therapy for body dysmorphic disorder: A systematic review and meta-analysis of randomized controlled trials. Clin Psychol Rev. 2016;48:43-51. https://doi.org/10.1016/j.cpr.2016.05.007
Phillips KA, Didie ER, Menard W, Pagano ME, Fay C, Weisberg RB. Clinical features of body dysmorphic disorder in adolescents and adults. Psychiatry Res. 2006;141(3):305-14. https://doi.org/10.1016/j.psychres.2005.09.014
Atmaca M, Bingol I, Aydin A, Yildirim H, Okur I, Yildirim MA et al. Brain morphology of patients with body dysmorphic disorder. J Affect Disord. 2010;123(1-3):258-63. https://doi.org/10.1016/j.jad.2009.08.012
Phillips KA, Zai G, King NA, Menard W, Kennedy JL, Richter MA. A preliminary candidate gene study in body dysmorphic disorder. J Obsessive Compuls Relat Disord. 2015;6:72-6. https://doi.org/10.1016/j.jocrd.2015.06.004
Phillips KA. Body dysmorphic disorder: Assessment, diagnosis, and differential diagnosis. Uptodate 2018.